Romidepsin for the Treatment of Peripheral T-Cell Lymphoma.
about
Antitumor activity and pharmacologic characterization of the depsipeptide analog as a novel histone deacetylase/ phosphatidylinositol 3-kinase dual inhibitor.Hepatoepigenetic Alterations in Viral and Nonviral-Induced Hepatocellular Carcinoma.Food Bioactive HDAC Inhibitors in the Epigenetic Regulation of Heart Failure
P2860
Romidepsin for the Treatment of Peripheral T-Cell Lymphoma.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Romidepsin for the Treatment of Peripheral T-Cell Lymphoma.
@ast
Romidepsin for the Treatment of Peripheral T-Cell Lymphoma.
@en
type
label
Romidepsin for the Treatment of Peripheral T-Cell Lymphoma.
@ast
Romidepsin for the Treatment of Peripheral T-Cell Lymphoma.
@en
prefLabel
Romidepsin for the Treatment of Peripheral T-Cell Lymphoma.
@ast
Romidepsin for the Treatment of Peripheral T-Cell Lymphoma.
@en
P2860
P1433
P1476
Romidepsin for the Treatment of Peripheral T-Cell Lymphoma
@en
P2093
Francine F Foss
P2860
P304
P356
10.1634/THEONCOLOGIST.2015-0043
P577
2015-06-22T00:00:00Z